Alzheimer's Disease Trial, Recruiting NCT05534607 Sponsor: University of Hawaii Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05534607
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You identify as Native Hawaiian or other Pacific Islander
  • You are between 50 and 75 years old
  • You have noticed changes in your memory or thinking, or have been told by a doctor that you have mild cognitive impairment
  • You have been diagnosed with at least one of the following: high blood pressure, diabetes, high cholesterol, or obesity (a BMI of 30 or above)
  • You are physically able and willing to take part in moderate physical activity, such as Hula dancing
  • Your doctor has given you approval to do moderate physical activity

Who may not be able to join:

  • You are currently pregnant
  • You already practice Hula dancing at least once a week
  • You have been diagnosed with Alzheimer's disease or a related dementia condition
  • You have been diagnosed with moderate or severe major depression, or you score at a moderate or higher level for depression on a standard depression questionnaire (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joseph K Kaholokula, PhD, University of Hawaii

Phone: 8086921023

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Hawaii
Registry
ClinicalTrials.gov
Start date
15 September 2022
Est. completion
15 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in participants' systolic blood pressure at each time frame from baseline; Change in participants' Hemoglobin A1c at each time frame from baseline; Change in participants' total cholesterol at each time frame from baseline; Change in participants' body mass index at each time frame from baseline; Change in participants' Cognitive Change Index score at each time frame from baseline; Change in participants' Number Symbol Coding Test score at each time frame from baseline; Change in participants' overall Cognivue score at each time frame from baseline; Change in participants' overall Quick...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov